Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1972
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1983 1
1986 1
1987 2
1988 4
1989 4
1990 4
1991 2
1992 5
1993 9
1994 11
1995 14
1996 9
1997 8
1998 9
1999 10
2000 12
2001 7
2002 10
2003 6
2004 17
2005 15
2006 9
2007 11
2008 9
2009 6
2010 11
2011 12
2012 36
2013 18
2014 20
2015 9
2016 24
2017 21
2018 20
2019 22
2020 17
2021 18
2022 20
2023 10
2024 18
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

439 results

Results by year

Filters applied: . Clear all
Page 1
Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update.
Ranganathan S, Lopez-Terrada D, Alaggio R. Ranganathan S, et al. Pediatr Dev Pathol. 2020 Mar-Apr;23(2):79-95. doi: 10.1177/1093526619875228. Epub 2019 Sep 25. Pediatr Dev Pathol. 2020. PMID: 31554479 Review.
Hepatoblastomas (HBs) and pediatric hepatocellular carcinomas (HCCs) together account for almost 80% of primary malignant liver tumors in children and adolescents/young adults. ...
Hepatoblastomas (HBs) and pediatric hepatocellular carcinomas (HCCs) together account for almost 80% of primary malignant liver tumor
Surveillance guidelines for children with trisomy 18.
Kepple JW, Fishler KP, Peeples ES. Kepple JW, et al. Am J Med Genet A. 2021 Apr;185(4):1294-1303. doi: 10.1002/ajmg.a.62097. Epub 2021 Feb 2. Am J Med Genet A. 2021. PMID: 33527722 Review.
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
Sia D, Villanueva A, Friedman SL, Llovet JM. Sia D, et al. Gastroenterology. 2017 Mar;152(4):745-761. doi: 10.1053/j.gastro.2016.11.048. Epub 2016 Dec 30. Gastroenterology. 2017. PMID: 28043904 Free article. Review.
Primary liver cancer comprises hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA), and other rare tumors, notably fibrolamellar carcinoma and hepatoblastoma. The molecular and clinical features of HCC versus iCCA are distinct, but these conditions have …
Primary liver cancer comprises hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (iCCA), and other rare tumors, notably fibrol …
Current Approaches in Hepatoblastoma-New Biological Insights to Inform Therapy.
Wu PV, Rangaswami A. Wu PV, et al. Curr Oncol Rep. 2022 Sep;24(9):1209-1218. doi: 10.1007/s11912-022-01230-2. Epub 2022 Apr 19. Curr Oncol Rep. 2022. PMID: 35438389 Review.
PURPOSE OF REVIEW: As the most common pediatric primary liver cancer with rising incidence, hepatoblastoma remains challenging to treat. Here, we review the current understanding of the biology of hepatoblastoma and discuss how recent advances may lead to new treatm …
PURPOSE OF REVIEW: As the most common pediatric primary liver cancer with rising incidence, hepatoblastoma remains challenging to tre …
2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT).
Towbin AJ, Meyers RL, Woodley H, Miyazaki O, Weldon CB, Morland B, Hiyama E, Czauderna P, Roebuck DJ, Tiao GM. Towbin AJ, et al. Pediatr Radiol. 2018 Apr;48(4):536-554. doi: 10.1007/s00247-018-4078-z. Epub 2018 Feb 9. Pediatr Radiol. 2018. PMID: 29427028 Review.
Since its inception in 1992, the PRETEXT (PRE-Treatment EXTent of tumor) system has become the primary method of risk stratification for hepatoblastoma and pediatric hepatocellular carcinoma in numerous cooperative group trials across the world. ...
Since its inception in 1992, the PRETEXT (PRE-Treatment EXTent of tumor) system has become the primary method of risk stratification for …
Wnt-β-catenin signalling in liver development, health and disease.
Perugorria MJ, Olaizola P, Labiano I, Esparza-Baquer A, Marzioni M, Marin JJG, Bujanda L, Banales JM. Perugorria MJ, et al. Nat Rev Gastroenterol Hepatol. 2019 Feb;16(2):121-136. doi: 10.1038/s41575-018-0075-9. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30451972 Review.
A substantial proportion of liver tumours (mainly HCC and, to a lesser extent, CCA) have mutations in genes encoding key components of the Wnt-beta-catenin signalling pathway. Likewise, hepatoblastoma, the most common paediatric liver cancer, is characterized by Wnt-beta-c …
A substantial proportion of liver tumours (mainly HCC and, to a lesser extent, CCA) have mutations in genes encoding key components of the W …
Molecular Characteristics of Cisplatin-Induced Ototoxicity and Therapeutic Interventions.
Tan WJT, Vlajkovic SM. Tan WJT, et al. Int J Mol Sci. 2023 Nov 20;24(22):16545. doi: 10.3390/ijms242216545. Int J Mol Sci. 2023. PMID: 38003734 Free PMC article. Review.
Cisplatin is also used to treat tumors in children, such as neuroblastoma, osteosarcoma, and hepatoblastoma. However, its clinical use is limited by severe side effects, including ototoxicity, nephrotoxicity, neurotoxicity, hepatotoxicity, gastrointestinal toxicity, and re …
Cisplatin is also used to treat tumors in children, such as neuroblastoma, osteosarcoma, and hepatoblastoma. However, its clinical us …
Review of Ginkgo biloba-induced toxicity, from experimental studies to human case reports.
Mei N, Guo X, Ren Z, Kobayashi D, Wada K, Guo L. Mei N, et al. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2017 Jan 2;35(1):1-28. doi: 10.1080/10590501.2016.1278298. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2017. PMID: 28055331 Free PMC article. Review.
The National Toxicology Program conducted 2-year gavage studies on one Ginkgo biloba leaf extract and concluded that there was clear evidence of carcinogenic activity of this extract in mice based on an increased incidence of hepatocellular carcinoma and hepatoblastoma. Re …
The National Toxicology Program conducted 2-year gavage studies on one Ginkgo biloba leaf extract and concluded that there was clear evidenc …
439 results